Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,208

Sort by:

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021

US$ 3,500.00

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 SUMMARY 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5?-Nucleotidase (5NT) i...

November 2021 145 pages

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021

US$ 2,000.00

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic...

November 2021 170 pages

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021

US$ 3,500.00

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021 SUMMARY Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Bcl-2-like protein 1 is a pro...

November 2021 66 pages

Bladder Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Bladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides...

November 2021 2564 pages

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bullous Pemphigoid - Drugs In Development, 202...

November 2021 177 pages

Canavan Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Canavan Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Drugs In Development...

November 2021 35 pages

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) pipeline Target constitutes c...

November 2021 51 pages

Encephalopathy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Encephalopathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Drugs In Development,...

November 2021 113 pages

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastrointestinal Stromal Tumor...

November 2021 866 pages

Gaucher Disease - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...

November 2021 143 pages

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid C...

November 2021 79 pages

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Drugs In Development, 20...

November 2021 102 pages

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection - Drugs In D...

November 2021 40 pages

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

November 2021 157 pages

Huntington Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Huntington Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Drugs In Devel...

November 2021 423 pages

Hypertension (Cardiovascular) - Drugs in Development, 2021

US$ 2,500.00

Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...

November 2021 872 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021

US$ 3,500.00

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Integrin Alpha 4 - Drugs I...

November 2021 126 pages

Keloids (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...

November 2021 51 pages

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure - Drugs...

November 2021 143 pages

Macular Edema (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...

November 2021 102 pages

Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...

November 2021 4610 pages

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leuko...

November 2021 51 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis I - Dru...

November 2021 110 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis II -...

November 2021 88 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis...

November 2021 115 pages

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Drugs In Devel...

November 2021 1320 pages

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Health...

November 2021 127 pages

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome - Drugs In Develop...

November 2021 2188 pages

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Drugs In Development...

November 2021 92 pages

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021

US$ 2,000.00

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type...

November 2021 256 pages

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules...

November 2021 76 pages

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Non Receptor Tyrosine Protein Kinase TYK2 - Drugs In De...

November 2021 123 pages

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021

US$ 2,000.00

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency - D...

November 2021 69 pages

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

US$ 3,500.00

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This...

November 2021 70 pages

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers - Drugs In Development, 2021, pr...

November 2021 77 pages

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis - Drugs In Developmen...

November 2021 143 pages

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclea...

November 2021 136 pages

Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provid...

November 2021 4131 pages

Radiodermatitis - Drugs in Development, 2021

US$ 2,000.00

Radiodermatitis - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Drugs In Development, 2021, provides an overv...

November 2021 73 pages

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene...

November 2021 113 pages

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021

US$ 3,500.00

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021 SUMMARY Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close...

November 2021 40 pages

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Drugs In Develo...

November 2021 138 pages

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Drugs In Develop...

November 2021 84 pages

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome - Drugs In Development, 20...

November 2021 274 pages

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Drugs In Development...

November 2021 2115 pages

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021

US$ 3,500.00

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Sodium And Ch...

November 2021 42 pages

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinas...

November 2021 63 pages

Usher Syndrome - Drugs in Development, 2021

US$ 2,000.00

Usher Syndrome - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome - Drugs In Development, 2021, provides an overvie...

November 2021 82 pages

Wilson Disease - Drugs in Development, 2021

US$ 2,000.00

Wilson Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Drugs In Development, 2021, provides an overvie...

November 2021 69 pages

Wounds (Dermatology) - Drugs in Development, 2021

US$ 2,500.00

Wounds (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Drugs In Development, 2021, provides an overview...

November 2021 274 pages

Filters

Clear all